Showing results (501-510 of 1,091) with videos related to
Sort By:
Pageof 110
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2003
Prognostic significance of MUC-1 expression in systemic anaplastic large cell lymphomaGeorge Z Rassidakis, Andre Goy, L Jeffrey Medeiros, et al.Journal of Clinical Pathology|June 12, 2012
Immunophenotypic heterogeneity of normal plasma cells: comparison with minimal residual plasma cell myelomaDingsheng Liu, Pei Lin, Ying Hu, et al.Journal of Hematology & Oncology|October 31, 2015
Establishment and characterization of a novel MYC/BCL2 "double-hit" diffuse large B cell lymphoma cell line, RCLan V Pham, Gary Lu, Archito T Tamayo, et al.Leukemia Research|November 9, 2020
Myeloid/lymphoid neoplasms with eosinophilia and FLT3 rearrangementHaipeng Shao, Wei Wang, Jinming Song, et al.Experimental and Molecular Pathology|April 21, 2019
Acute myeloid leukemia with t(8;21)(q22;q22.1)/RUNX1-RUNX1T1 and KIT Exon 8 mutation is associated with characteristic mastocytosis and dismal outcomesWei Xie, Sa A Wang, C Cameron Yin, et al.Cancer|April 2, 2011
Phosphorylated CXCR4 is associated with poor survival in adults with B-acute lymphoblastic leukemiaSergej Konoplev, Jeffrey L Jorgensen, Deborah A Thomas, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 19, 2006
MALT1 gene rearrangements and NF-kappaB activation involving p65 and p50 are absent or rare in primary MALT lymphomas of the breastSameer S Talwalkar, Jose R Valbuena, Lynne V Abruzzo, et al.Haematologica|April 11, 2020
MYC rearrangement but not extra MYC copies is an independent prognostic factor in patients with mantle cell lymphomaLifu Wang, Guilin Tang, L Jeffrey Medeiros, et al.Blood|September 18, 2004
Inhibition of Akt increases p27Kip1 levels and induces cell cycle arrest in anaplastic large cell lymphomaGeorge Z Rassidakis, Marianna Feretzaki, Coralyn Atwell, et al.Annals of Hematology|February 20, 2022
3'CBFB deletion in CBFB-rearranged acute myeloid leukemia retains morphological features associated with inv(16), but patients have higher risk of relapse and may require stem cell transplantGuilin Tang, Ying Zou, Sa A Wang, et al.Pageof 110